treatment options for patients with multiple myeloma who are resistant to daratumumab
Published 1 year ago • 220 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
4:43
treatment options for patients with advanced multiple myeloma
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
4:10
treatment-free intervals for patients with myeloma
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
1:47
treatment options for penta-refractory multiple myeloma
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
1:25
the current approach to managing patients with prefibrotic pmf
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
1:57
what is the survival rate for multiple myeloma?
-
2:38
how close is a cure for multiple myeloma?
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
0:58
assessing treatment options for multiple myeloma: the importance of genetics
-
4:01
kenneth anderson: what are the next steps to a myeloma cure?
-
2:30
a new era of treatment for multiple myeloma
-
2:11
perspectives on the treatment of patients with r/r multiple myeloma
-
1:39
optimal treatment regimens for multiple myeloma
-
1:42
treatment options for transplant-ineligble myeloma patients: the promise of combination therapies
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
2:35
resistance to immunotherapy in multiple myeloma: mechanisms & monitoring
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
4:13
daratumumab as maintenance therapy after autosct in patients with multiple myeloma